Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources

The Real-World Effect of Intravitreous Anti–Vascular Endothelial Growth Factor Drugs on Intraocular Pressure

(2018) Elizabeth A. Atchison et al.   OPHTHALMOLOGY

Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors

(2018) Hemal Mehta et al.   PROGRESS IN RETINAL AND EYE RESEARCH

From Trial to Target Populations — Calibrating Real-World Data

(2017) Mehdi Najafzadeh et al.   NEW ENGLAND JOURNAL OF MEDICINE

The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting

(2017) Tsukasa Hanemoto et al.   PLoS One

Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration

(2016) Ian A. Rodrigues et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Real-World Evidence — What Is It and What Can It Tell Us?

(2016) Rachel E. Sherman et al.   NEW ENGLAND JOURNAL OF MEDICINE

How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review

(2016) Deanna J Taylor et al.   BMJ Open

Depression and burden among the caregivers of visually impaired patients: a systematic review

(2016) Robin K. Kuriakose et al.   INTERNATIONAL OPHTHALMOLOGY

A global overview of renal registries: a systematic review

(2015) Frank Xiaoqing Liu et al.   BMC Nephrology

Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment

(2014) Paul Mitchell et al.   PLoS One

The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data

(2014) Sarah R Dawson et al.   BMC Ophthalmology

Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis

(2014) Wan Ling Wong et al.   Lancet Global Health

Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review

(2013) Tien Y. Wong et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

(2012) J. W. Y. Yau et al.   DIABETES CARE

Current and future therapies for age-related macular degeneration

(2009) Julia Beutel et al.   EXPERT OPINION ON EMERGING DRUGS

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE